| 2020-09-28 | Class changed from VUS4 to disease-causing ; subclass remains unknown |
| 2021-01-18 | subclass updated from not defined to CFTR-RD-causing |
Variant NM_000492.4:c.349C>G
| Name | NM_000492.4:c.349C>G |
| Protein name | NP_000483.3:p.(Arg117Gly) |
| Genomic name (hg19) | chr7:g.117171028C>G UCSC |
| Genomic name (hg38) | chr7:g.117530974C>G UCSC |
| #Exon/intron | exon 4 |
| Legacy Name | R117G |
| Class | disease-causing |
| Subclass | CFTR-RD-causing |
| WT sequence | CTATGACCCGGATAACAAGGAGGAA C GCTCTATCGCGATTTATCTAGGCAT |
| Mutant sequence | CTATGACCCGGATAACAAGGAGGAA G GCTCTATCGCGATTTATCTAGGCAT |
![]() |
![]() | dbSNP rs77834169 |
![]() | ![]() |
| Modulator | FDA approval | EMA approval | in vitro / ex vivo data | clinical data |
| IVA | yes | no | yes | no |
| TEZ-IVA | yes | no | yes | no |
| ELX-TEZ-IVA | yes | no | yes | no |
clinical and functional data presented above are provided by Vertex
No patient found in CFTR-NGS catalogue |
| TOTAL NUMBER OF PATIENTS | 4 |
|---|---|
| CFTR-RD | 3
|
| Pending (NBS) | 1 |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| Phenotype | Patient ID | Variant status | Additional variants |
|---|---|---|---|
| Other | 935 | heterozygote | |
| CBAVD | 5330 | heterozygote | CF-causing- Undef |
| CBAVD | 5281 | heterozygote | CFTR-RD-causing - Trans |
| Pending (NBS) | 6030 | heterozygote | CF-causing - Trans |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| CFTR variants are clustered into five groups (click here for more details about the classification of variants): |
|